EMAIL THIS PAGE TO A FRIEND

The Journal of clinical investigation

Neural peptidase endothelin-converting enzyme 1 regulates endothelin 1-induced pruritus.


PMID 24812665

Abstract

In humans, pruritus (itch) is a common but poorly understood symptom in numerous skin and systemic diseases. Endothelin 1 (ET-1) evokes histamine-independent pruritus in mammals through activation of its cognate G protein-coupled receptor endothelin A receptor (ETAR). Here, we have identified neural endothelin-converting enzyme 1 (ECE-1) as a key regulator of ET-1-induced pruritus and neural signaling of itch. We show here that ETAR, ET-1, and ECE-1 are expressed and colocalize in murine dorsal root ganglia (DRG) neurons and human skin nerves. In murine DRG neurons, ET-1 induced internalization of ETAR within ECE-1-containing endosomes. ECE-1 inhibition slowed ETAR recycling yet prolonged ET-1-induced activation of ERK1/2, but not p38. In a murine itch model, ET-1-induced scratching behavior was substantially augmented by pharmacological ECE-1 inhibition and abrogated by treatment with an ERK1/2 inhibitor. Using iontophoresis, we demonstrated that ET-1 is a potent, partially histamine-independent pruritogen in humans. Immunohistochemical evaluation of skin from prurigo nodularis patients confirmed an upregulation of the ET-1/ETAR/ECE-1/ERK1/2 axis in patients with chronic itch. Together, our data identify the neural peptidase ECE-1 as a negative regulator of itch on sensory nerves by directly regulating ET-1-induced pruritus in humans and mice. Furthermore, these results implicate the ET-1/ECE-1/ERK1/2 pathway as a therapeutic target to treat pruritus in humans.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

90245
2,3,4-Tri-O-acetyl-α-D-arabinopyranosyl isothiocyanate, for chiral derivatization, ≥98.0%
C12H15NO7S
108146
Benzenesulfonamide, ≥98%
C6H7NO2S
M2028
Capsaicin, ≥95%, from Capsicum sp.
C18H27NO3
12084
Capsaicin, analytical standard
C18H27NO3
PHR1450
Capsaicin, Pharmaceutical Secondary Standard; Certified Reference Material
C18H27NO3
1091108
Capsaicin, United States Pharmacopeia (USP) Reference Standard
C18H27NO3
Y0000671
Capsaicin, European Pharmacopoeia (EP) Reference Standard
C18H27NO3
360376
Capsaicin, natural
C18H27NO3
21750
Capsaicin, from Capsicum sp., ≥50% (HPLC)
C18H27NO3
D3630
Diphenhydramine hydrochloride, ≥98% (HPLC)
C17H21NO · HCl
D2600000
Diphenhydramine hydrochloride, European Pharmacopoeia (EP) Reference Standard
C17H21NO · HCl
1218005
Diphenhydramine hydrochloride, United States Pharmacopeia (USP) Reference Standard
C17H21NO · HCl
PHR1015
Diphenhydramine hydrochloride, Pharmaceutical Secondary Standard; Certified Reference Material
C17H21NO · HCl
E7764
Endothelin 1, ≥97% (HPLC), powder
C109H159N25O32S5
59964
Histamine, analytical standard
C5H9N3
H7125
Histamine, ≥97.0%
C5H9N3
SRP3209 IL-31 from mouse, recombinant, expressed in E. coli, ≥98% (SDS-PAGE), ≥98% (HPLC), cell culture tested
SRP3091 IL-31 human, recombinant, expressed in E. coli, ≥98% (SDS-PAGE), ≥98% (HPLC), cell culture tested
W326305
L-Cysteine, ≥97%, FG
C3H7NO2S
168149
L-Cysteine, 97%
C3H7NO2S
C7352
L-Cysteine, from non-animal source, BioReagent, suitable for cell culture, ≥98%
C3H7NO2S
C5360
L-Cysteine, PharmaGrade, from non-animal source, Ajinomoto, manufactured under appropriate GMP controls for Pharma or Biopharmaceutical production, suitable for cell culture
C3H7NO2S
30089
L-Cysteine, BioUltra, ≥98.5% (RT)
C3H7NO2S
778672
L-Cysteine, produced by Wacker Chemie AG, Burghausen, Germany, ≥98.0%
C3H7NO2S
95437
L-Cysteine, certified reference material, TraceCERT®
C3H7NO2S
S9317
PAR-2 (1-6) amide (mouse, rat) trifluoroacetate salt, ≥97% (HPLC)
C29H56O7N10 · C2HF3O2